The article highlights significant uncertainty around BZAI's ability to meet its $130M full-year guide, citing poor Q1 revenue and unresolved cash collection issues with NeoTensr. This risks a negativ
The article highlights significant uncertainty around BZAI's ability to meet its $130M full-year guide, citing poor Q1 revenue and unresolved cash collection issues with NeoTensr. This risks a negative re-rating if management fails to deliver a credible path to H2 acceleration.
Risk: Revenue concentration, customer payment delays, and execution risk on the steep ramp.